Cargando…
Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice
INTRODUCTION: In this study, we report a novel therapeutic approach using B lymphocytes to attract islet-specific T cells in the non-obese diabetic (NOD) mouse model and prevent the development of autoimmune diabetes. Rather than using the antibody receptor of B cells, this approach utilizes their p...
Autores principales: | Chen, Dawei, Kakabadse, Dimitri, Fishman, Sigal, Weinstein-Marom, Hadas, Davies, Joanne, Boldison, Joanne, Thayer, Terri C., Wen, Li, Gross, Gideon, Wong, F. Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507356/ https://www.ncbi.nlm.nih.gov/pubmed/37731505 http://dx.doi.org/10.3389/fimmu.2023.1227133 |
Ejemplares similares
-
B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model
por: Da Rosa, Larissa C., et al.
Publicado: (2018) -
Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction
por: Weinstein-Marom, Hadas, et al.
Publicado: (2021) -
Regulatory B Cells: Role in Type 1 Diabetes
por: Boldison, Joanne, et al.
Publicado: (2021) -
Phenotypically distinct anti-insulin B cells repopulate pancreatic islets after anti-CD20 treatment in NOD mice
por: Boldison, Joanne, et al.
Publicado: (2019) -
Implementing Logic Gates for Safer Immunotherapy of Cancer
por: Savanur, Mohammed Azharuddin, et al.
Publicado: (2021)